The contact precautions controversy

American Journal of Nursing

Volumn 111, Issue 3, 2011, Pages 47-53

  Zastrow, Rachel L ^a,b  

^a CENTRAL DUPAGE HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; EVIDENCE BASED MEDICINE; FEMALE; HETEROZYGOTE; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MULTIDRUG RESISTANCE; PATIENT CARE; PSYCHOLOGICAL ASPECT; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ADULT; CARRIER STATE; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT ISOLATION; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; VANCOMYCIN RESISTANCE;

EID: 79952139383     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/10.1097/01.NAJ.0000395242.14347.37     Document Type: Review

References (41)

1. Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infec tious agents in healthcare settings. Atlanta: Centers for Disease Control and Prevention; 2007. http://www.cdc.gov/hicpac/2007IP/2007ip-part1.html#2.
2. Association for Professionals in Infection Control and Epidemiology. MRSA laws and pending legislation Washington, DC; 2010. http://www.apic.org/ downloads/legislation/MRSA-map.gif.
3. Leavell HR, Clark EG, editors. Preventive medicine for the doctor in his community: an epidemiologic approach 3rd ed. New York: McGraw-Hill; 1965.
4. Hidron AI, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996-1011.
5. Vincent JL, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(21):2323-9.
6. Marshall C, et al. Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect 2004;56(4): 253-68. (Pubitemid 38444077)
7. Nelson EC, et al., editors. Quality by design: a clinical microsystems approach San Francisco: Jossey-Bass; 2007.
8. Blot S, et al. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007; 20(4):391-6. (Pubitemid 47026236)
9. Cosgrove SE, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36(1):53-9. (Pubitemid 36099097)
10. Wertheim HF, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364(9435):703-5. (Pubitemid 39140626)
11. Cimolai N. MRSA and the environment: implications for comprehensive control measures. Eur J Clin Microbiol Infect Dis 2008;27(7):481-93.
12. Weist K, et al. An outbreak of pyodermas among neonates caused by ultrasound gel contaminated with methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2000;21(12):761-4. (Pubitemid 32010218)
13. Wilcox MH, et al. A five year out-break of methicillin-susceptible Staphylococcus aureus phage type 53, 85 in a regional neonatal unit. Epidemiol Infect 2000;124(1):37-45. (Pubitemid 30103407)
14. Lin MF, et al. Investigation of a pyoderma outbreak caused by methicillin-susceptible Staphylococcus aureus in a nursery for newborns. J Hosp Infect 2004;57(1):38-43. (Pubitemid 38594519)
15. Snyder GM, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol 2008;29(7):583-9. (Pubitemid 352009381)
16. Girou E, et al. Misuse of gloves: the foundation for poor compliance with hand hygiene and potential for microbial transmission? J Hosp Infect 2004; 57(2):162-9. (Pubitemid 38745430)
17. Aboelela SW, et al. Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control 2006;34(8):484-94. (Pubitemid 44466131)
18. Cepeda JA, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005;365(9456):295-304. (Pubitemid 40139106)
19. Slaughter S, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125(6):448-56. (Pubitemid 126690036)
20. Trick WE, et al. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc 2004;52(12):2003-9. (Pubitemid 41725015)
21. Silverblatt FJ, et al. Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 2000;48(10):1211-5.
22. Chaix C, et al. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282 (18):1745-51. (Pubitemid 29533605)
23. Srinivasan A, et al. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002;23(8):424-8.
24. Wernitz MH, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 2005;11(6):457-65. (Pubitemid 40744392)
25. Kirkland KB, Weinstein JM. Adverse effects of contact isolation. Lancet 1999;354(9185):1177-8. (Pubitemid 29460451)
26. Lai KK, et al. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 1998;19(9):647-52. (Pubitemid 128472186)
27. Wilkins EG, et al. Does isolation of patients with infections induce mental illness? J Infect 1988;17(1):43-7.
28. Peel RK, et al. Is it time to stop searching for MRSA? Isolating patients with MRSA can have long term implications. BMJ 1997;315(7099):58.
29. Gammon J. Analysis of the stressful effects of hospitalisation and source isolation on coping and psychological constructs. Int J Nurs Pract 1998; 4(2):84-96.
30. Kennedy P, Hamilton LR. Psychological impact of the management of methicillin-resistant Staphylococcus aureus (MRSA) in patients with spinal cord injury. Spinal Cord 1997; 35(9):617-9. (Pubitemid 27401745)
31. Tarzi S, et al. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001;49(4):250-4.
32. Catalano G, et al. Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 2003;96(2):141-5. (Pubitemid 36268584)
33. Hegarty F, et al. Using multimedia technology to help combat the negative effects of protective isolation on patients: the Open Window project-an engineering challenge. J Vis Commun Med 2009;32(3-4):72-7.
34. Stelfox HT, et al. Safety of patients isolated for infection control. JAMA 2003;290(14):1899-905. (Pubitemid 37430607)
35. Gasink LB, et al. Contact isolation for infection control in hospitalized patients: is patient satisfaction affected? Infect Control Hosp Epidemiol 2008;29(3):275-8. (Pubitemid 351269195)
36. Evans HL, et al. Contact isolation in surgical patients: a barrier to care? Surgery 2003;134(2):180-8. (Pubitemid 37070337)
37. Saint S, et al. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003;31(6):354-6. (Pubitemid 37222812)
38. Knowles HE. The experience of infectious patients in isolation. Nurs Times 1993;89(30):53-6.
39. Weber SG, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staph ylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. Am J Infect Con trol 2007; 35(2):73-85.
40. Muto CA, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24(5):362-86. (Pubitemid 36612323)
41. Association for Professionals in Infection Control and Epidemiology. Guide to the elimination of methicillin-resistant staphylococcus aureus (MRSA) transmission in hospital settings. Washington, DC; 2007 Mar. http://www.apic.org/Content/NavigationMenu/PracticeGuidance/ APICEliminationGuides/ mrsa-elim-guide.pdf.